SEARCH

SEARCH BY CITATION

References

  • Alexander SPH, Mathie A, Peters JA (2011). Guide to Receptors and Channels (GRAC), 5th edition. Br J Pharmacol 164 (Suppl. 1): S1S324.
  • Basbaum AI, Fields HL (1984). Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci 7: 309338.
  • Basbaum AI, Jessell TM (2000). The perception of pain. In: Kandel ER , Schwartz JH , Jessell TM (eds). Principles of Neural Science. McGraw-Hill: New York, pp. 472491.
  • Becker R, Jakob D, Uhle EI, Riegel T, Bertalanffy H (2000). The significance of intrathecal opioid therapy for the treatment of neuropathic cancer pain conditions. Stereotact Funct Neurosug 75: 1626.
  • Bercovitch M, Adunsky A (2006). High dose controlled-release oxycodone in hospice care. J Pain Palliat Care Pharmacother 20: 3339.
  • Birukova AA, Adyshev D, Gorshkov B, Bokoch GM, Birukov KG, Verin AD (2006). GEF-H1 is involved in agonist-induced human pulmonary endothelial barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 390: L540L548.
  • Brunton J, Charpak S (1998). mu-Opioid peptides inhibit thalamic neurons. J Neurosci 18: 16711678.
  • Chen Y, Mestek A, Liu J, Hurley JA, Yu L (1993). Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Mol Pharmacol 44: 812.
  • Cherny N (2000). New strategies in opioid therapy for cancer pain. J Oncol Manage 9: 815.
  • Cohen SR, Melzack R (1985). Morphine injected into the habenula and dorsal posteromedial thalamus produces analgesia in the formalin test. Brain Res 359: 131139.
  • Cordeaux Y, Briddon SJ, Megson AE, Mcdonnell J, Dickenson J (2000). Influence of receptor number on functional responses elicited by agonists acting at the human adenosine A1 receptor: evidence for signalling pathway-dependent changes in agonist potency and relative intrinsic activity. Mol Pharmacol 58: 10752000.
  • Cox BM, Weinstock M (1964). Quantitative studies of the antagonism by nalorphine of some of the actions of morphine-like analgesia drugs. Br J Pharmacol 22: 289300.
  • Gimbel JS, Richards P, Portenoy RK (2003). Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial. Neurology 60: 927934.
  • Heiskanen T, Kalso E (1997). Controlled-release oxycodone and morphine in cancer related pain. Pain 73: 3745.
  • Honore P, Lugar NM, Sabino MAC, Schwei MJ, Rogers SD, Mash DB et al. (2000). Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-induced neurochemical reorganization of the spinal cord. Nat Med 6: 521528.
  • Kalso E (2005). Oxycodone. J Pain Symptom Manage 29: S47S56.
  • Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG (2010) NC3Rs Reporting Guidelines Working Group.Br J Pharmacol 160: 15771579.
  • Komiya S, Zenmyo M, Inoue A (1999). Bone tumors in the pelvis presenting growth during pregnancy. Arch Orthop Trauma Surg 119: 2229.
  • Koshy RC, Rhodes D, Devi A, Grossman SA (1998). Cancer pain management in developing countries: a mosaic of complex issues resulting in inadequate analgesia. Support Care Cancer 6: 430437.
  • Lazareno S (1997). Measurement of agonist-stimulated [35S]GTPγS binding to cell membranes. Methods Mol Biol 83: 107116.
  • Lemberg KK, Kontinen VK, Siiskonen AO, Viljakka KM, Yli-Kauhaluoma JT, Korpi ER et al. (2006). Antinociception by spinal and systemic oxycodone: why does the route make a difference? In vitro and in vivo studies in rats. Anesthesiology 105: 801812.
  • Levy MH (1996). Pharmacologic treatment of cancer pain. N Engl J Med 10: 11241132.
  • Luger NM, Sabino MA, Schwei MJ, Mach DB, Pomonis JD, Keyser CP et al. (2002). Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs inflammatory pain. Pain 99: 397406.
  • McDonald J, Barnes TA, Okawa H, Williams J, Calo G, Rowbotham DJ et al. (2003). Partial agonist behaviour depends upon the level of nociceptin/orphanin FQ receptor expression: studies using the ecdysone-inducuble mammalian expression system. Br J Pharmacol 140: 6170.
  • McGrath J, Drummond G, McLachlan E, Kilkenny C, Wainwright C (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 15731576.
  • Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE (1976). The effects of morphine and nalorphine-like drugs in the nondependent and morphine dependent chronic spinal dog. J Pharmacol Exp Ther 197: 517532.
  • Mercadante S, Arcuri E (1998). Breakthrough pain in cancer patients: pathophysiology and treatment. Cancer Treat Rev 24: 425432.
  • Min BH, Augustin LB, Felsheim RF, Fuchs JA, Loh HH (1994). Genomic structure and analysis of promoter sequence of a mouse μ opioid receptor gene. Proc Natl Acad Sci U S A 91: 90819085.
  • Minami K, Hasegawa M, Ito H, Nakamura A, Tomii T, Matsumoto M et al. (2009). Morphine, oxycodone, and fentanyl exhibit different analgesic profiles in mouse pain models. J Pharmacol Sci 111: 6072.
  • Narita M, Mizoguchi H, Narita M, Sora I, Uhl GR, Tseng LF (1999). Absence of G-protein activation by μ-opioid receptor knockout mice. Br J Pharmacol 123: 451456.
  • Narita M, Mizoguchi H, Narita M, Nagase H, Suzuki T, Tseng LF (2001). Involvement of spinal protein kinase Cγ in the attenuation of opioid μ-receptor-mediated G-protein activation after chronic intrathecal administration of [D-Ala2, N-MePhe4, Gly-Ol5] enkephalin. J Neurosci 21: 37153720.
  • Narita M, Nakamura A, Ozaki M, Imai S, Miyoshi K, Suzuki M et al. (2008). Comparative pharmacological profiles of morphine and oxycodone under a neuropathic pain-like state in mice: evidence for less sensitivity to morphine. Neuropsychopharmacology 33: 10971112.
  • Nielsen CK, Ross FB, Lotfipour S, Saini KS, Edwards SR, Smith MT (2007). Oxycodone and morphine have distinctly different pharmacological profiles: radioligand binding and behavioural studies in two rat models of neuropathic pain. Pain 132: 289300.
  • Pandit-Taskar N, Batraki M, Divgi CR (2004). Radiopharmaceutical therapy for palliation of bone pain from osseous metastases. J Nucl Med 45: 13581365.
  • Paxinos G, Franklin KBJ (2008). The Mouse Brain in Stereotaxic Coordinates. Academic Press: New York, NY.
  • Peckham EM, Traynor JR (2006). Comparison of the antinociceptive responses to morphine and morphine-like compounds in male and female Sprague-Dawley rats. J Pharmacol Exp Ther 316: 11951201.
  • Pert CB, Snyder SH (1973). Opiate receptor: demonstration in nervous tissue. Science 179: 10111014.
  • Portenoy RK, Payne D, Jacobsen P (1999). Breakthrough pain: characteristics and impact in patients with cancer pain. Pain 81: 129134.
  • Ross FB, Smith MT (1997). The intrinsic antinociceptive effects of oxycodone appear to be κ-opioid receptor mediated. Pain 73: 151157.
  • Silvestri B, Bandieri E, Del Prete S, Ianniello GP, Micheletto G, Dambrosio M et al. (2008). Oxycodone controlled-release as first-choice therapy for moderate-to-severe cancer pain in Italian patients: results of an open-label, multicentre, observational study. Clin Drug Investig 28: 399407.
  • Veatch RM, Adler TK, Way EL (1964). The importance of steric configuration in certain morphine-mimetics of synthetic analgetics. J Pharmacol Exp Ther 145: 1119.
  • Watson CP, Babul N (1998). Efficacy of oxycodone in neuropathic pain. A randomized trial in post herpetic neuralgia. Neurology 50: 18371841.
  • Watson CP, Moulin D, Watt-Watson J, Gordon A, Eisenhoffer J (2003). Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain 105: 7178.
  • Yamamoto J, Kawamata T, Niiyama Y, Omote K, Namiki A (2008). Down-regulation of mu opioid receptor expression within distinct subpopulations of dorsal root ganglion neurons in a murine model of bone cancer pain. Neuroscience 6: 843853.
  • Zangen A, Herzberg U, Vogel Z, Yadid G (1998). Nociceptive stimulus induced release of endogenous beta-endorphin in the rat brain. Neuroscience 85: 659662.
  • Zhao C, Chen L, Tao YX, Tall JM, Borzan J, RingKamp M et al. (2007). Lumbar sympathectomy attenuates cold allodynia but not mechanical allodynia and hyperalgesia in rats with spared nerve injury. J Pain 8: 931937.
  • Zubieta JK, Smith YR, Bueller JA, Xu Y, Kilbourn MR, Jewett DM et al. (2001). Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science 293: 311315.